Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Colorectal Cancer (MCRC)”

339 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 339 results

Testing effectiveness (Phase 2)Ended earlyNCT03099486
What this trial is testing

Regorafenib Plus 5-Fluorouracil/Leucovorin Beyond Progression in mCRC

Who this might be right for
Colorectal Cancer
Fox Chase Cancer Center 2
Not applicableUnknownNCT03259009
What this trial is testing

RAS Mutations in ctDNA and Anti-EGFR reINTROduction in mCRC (RASINTRO)

Who this might be right for
Metastatic Colorectal Cancer
Association des Gastroentérologues Oncologues 73
Not applicableStudy completedNCT02624895
What this trial is testing

ObservationaL Study on the Qol of RAS Wild-type mCRC Patients Receiving Anti-EGFR MAbs + FOLFOX or FOLFIRI as 1st Line

Who this might be right for
Metastatic Colorectal Cancer
Amgen 296
Testing effectiveness (Phase 2)UnknownNCT04034459
What this trial is testing

FOLFOXIRI Plus Cetuximab vs. FOLFOXIRI Plus Bevacizumab 1st-line in BRAF-mutated mCRC

Who this might be right for
Metastatic Colorectal Cancer
Ludwig-Maximilians - University of Munich 109
Large-scale testing (Phase 3)UnknownNCT03909724
What this trial is testing

Pulsatile High-dose Sunitinib Versus TAS-102 in Patients With Metastatic Colorectal Carcinoma (mCRC)

Who this might be right for
Colorectal CancerMetastasis
Amsterdam UMC, location VUmc 60
Testing effectiveness (Phase 2)Study completedNCT01374425
What this trial is testing

Study of Bevacizumab + mFOLFOX6 Versus Bevacizumab + FOLFIRI With Biomarker Stratification in Participants With Previously Untreated Metastatic Colorectal Cancer (mCRC)

Who this might be right for
Colorectal Cancer
Genentech, Inc. 376
Testing effectiveness (Phase 2)Looking for participantsNCT05319314
What this trial is testing

LYL273 for Patients With Relapsed or Refractory mCRC

Who this might be right for
Colorectal Cancer
Lyell Immunopharma, Inc. 155
Not applicableUnknownNCT01756625
What this trial is testing

PREMIUM, Observational Study

Who this might be right for
First Line WT KRAS mCRC
Dr.Laurent Mineur 500
Not applicableStudy completedNCT02256800
What this trial is testing

Escalated Dose of Irinotecan in mCRC

Who this might be right for
Metastatic Colorectal Cancer
Jaw-Yuan Wang, MD, PhD 213
Testing effectiveness (Phase 2)UnknownNCT04759664
What this trial is testing

LUT014 for the Reduction of Dose-Limiting Acneiform Lesions Associated With EGFRI Treatment of mCRC

Who this might be right for
EGFRI Induced Acneiform Lesions
Lutris Pharma Ltd. 117
Testing effectiveness (Phase 2)UnknownNCT06379399
What this trial is testing

Trifluridine/Tipiracil Combined With Cetuximab in the Treatment of Third-line and Above RAS/BRAF Wild-type mCRC

Who this might be right for
Colorectal Cancer Metastatic
Wangxia LV 26
Testing effectiveness (Phase 2)UnknownNCT05292417
What this trial is testing

Radiotherapy in Combination With Sintilimab，GM-CSF and Fruquintinib in Patients With MSS mCRC

Who this might be right for
Colorectal Neoplasms
The First Affiliated Hospital of Xiamen University 71
Early research (Phase 1)Ended earlyNCT04073615
What this trial is testing

Rivoceranib and Trifluridine/Tipiracil for Metastatic Colorectal Cancer (mCRC)

Who this might be right for
Metastatic Colorectal Cancer
Elevar Therapeutics 29
Testing effectiveness (Phase 2)Study completedNCT02651415
What this trial is testing

Phase II Study of Perindopril and Regorafenib in mCRC

Who this might be right for
Metastatic Colorectal Cancer
British Columbia Cancer Agency 12
Large-scale testing (Phase 3)Active Not RecruitingNCT04776655
What this trial is testing

Study in mCRC Patients RAS/BRAF wt Tissue and RAS Mutated LIquid BIopsy to Compare FOLFIRI Plus CetuxiMAb or BevacizumaB

Who this might be right for
Colorectal CancerMetastatic Colorectal CancerRAS Mutation
Azienda USL Reggio Emilia - IRCCS 280
Early research (Phase 1)Looking for participantsNCT05719558
What this trial is testing

ASP1002 in Adults for Treatment of Solid Tumors

Who this might be right for
Advanced Solid Tumors
Astellas Pharma Global Development, Inc. 798
Testing effectiveness (Phase 2)Ended earlyNCT00642746
What this trial is testing

Erlotinib and Chemotherapy for 2nd Line Treatment (Tx) of Metastatic Colorectal Cancer (mCRC)

Who this might be right for
Metastatic Colorectal Cancer
OHSU Knight Cancer Institute 16
Large-scale testing (Phase 3)Study completedNCT04835142
What this trial is testing

Comparison of A140 and Erbitux Combined With mfolfox6 to Evaluate Efficacy and Safety of First-line Treatment for Ras Wild-type mCRC

Who this might be right for
Metastatic Colorectal Cancer
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 688
Large-scale testing (Phase 3)Ended earlyNCT04607668
What this trial is testing

Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving FOLFOXIRI/Bevacizumab for Metastatic Colorectal Cancer (mCRC):

Who this might be right for
Colorectal Cancer MetastaticMyelosuppression-AdultChemotherapeutic Toxicity
G1 Therapeutics, Inc. 326
Testing effectiveness (Phase 2)Study completedNCT05061017
What this trial is testing

Pixatimod (PG545) Plus Nivolumab in PD-1 Relapsed/Refractory Metastatic Melanoma and NSCLC and With Nivolumab and Low-dose Cyclophosphamide in MSS Metastatic Colorectal Carcinoma (mCRC)

Who this might be right for
NSCLCMetastatic Colorectal CarcinomaRefractory Melanoma
Diwakar Davar 13
Next Page